发明申请
- 专利标题: Non-nucleoside reverse transcriptase inhibitors
- 专利标题(中): 非核苷逆转录酶抑制剂
-
申请号: US10719369申请日: 2003-11-21
-
公开(公告)号: US20050054639A1公开(公告)日: 2005-03-10
- 发明人: Bruno Simoneau , Anne-Marie Faucher , Serge Landry , Jeffrey O'Meara , Bounkham Thavonekham , Christiane Yoakim
- 申请人: Bruno Simoneau , Anne-Marie Faucher , Serge Landry , Jeffrey O'Meara , Bounkham Thavonekham , Christiane Yoakim
- 申请人地址: DE Ingelheim
- 专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人地址: DE Ingelheim
- 主分类号: A61K31/167
- IPC分类号: A61K31/167 ; A61K31/41 ; A61K31/4164 ; A61K31/4178 ; A61K31/4184 ; A61K31/4192 ; A61K31/4439 ; C07D233/84 ; C07D235/28 ; C07D249/12 ; C07D257/04 ; C07D257/06 ; C07D307/54 ; C07D401/04 ; C07D401/12 ; C07D403/12 ; C07D405/12 ; C07D409/12 ; A61K31/541 ; A61K31/422 ; A61K31/427 ; A61K31/496 ; A61K31/5377
摘要:
Disclosed herein are compounds of formula Ar1—X—W—Ar2 wherein Ar1 and Ar2 represent aryl groups characterized generally as aromatic heterocycles (e.g. imidazolyl or tetrazolyl) or carbocycles (e.g. phenyl or naphthalenyl); the aryl groups are optionally substituted or fused with other heterocycles or carbocycles; the aryl groups can bear substituents such as alkyl, halo or O-alkyl. X is a heteroatom, a valence bond or an optionally substituted divalent methylene, and W represents a spacer; typical spacers include divalent alkylene or alkylene-amido, -amido or -oxy radicals, which may optionally be substituted (e.g. hydroxyl or oxo). A typical compound is a derivative of 2-(N-napthalenyltetrazolylthio)-N-(2-nitrophenyl)acetamide. The compounds have inhibitory activity against Wild Type and single or double mutant strains of HIV.
公开/授权文献
- US07642277B2 Non-nucleoside reverse transcriptase inhibitors 公开/授权日:2010-01-05
信息查询